Professor of Medicinal Chemistry and Molecular Pharmacology

Program Co-Leader of Cell Identity and Signaling of Purdue University

             Center for Cancer Research (PCCR)

Program Co-Leader of Prostate Cancer Discovery Group of PCCR


Phone: (765) 496-1971

Fax: (765) 494-1414

Purdue Faculty Website

Specialization: Cancer Biology and Cancer Pharmacology


M.D. (1984) - Bengbu Medical College, China (Medicine)
M.S. (1987) - Tongji Medical University, China (Cancer Immunology)
Ph.D. (1997) - Kobe University, Japan (Molecular Biology)
Postdoc (2000-2002) - University of Michigan


Recent Awards

July 2017 - June 2021 - University Showalter Faculty Scholar Award of Purdue University

May 2019 - 2019 Chaney Faculty Scholar Award (Research Award in the Purdue University College of Pharmacy)

May 2018 - Lafayette Lions Club Award for Outstanding Achievements in Cancer Research (State Award)

October 2017 - Seed for Success Award (EVPRP)

April 2017 - Pharmaceutical Sciences Teacher of the Year in the College of Pharmacy


Recent Services in National and International Conferences

March 2020 - Invited Keynote Speaker (the 5th International Conference on Pharmacy and Pharmaceutical Sciences, Tokyo)

November 2019 - Session Co-Chair of Plenary Session I (Big Data as Engines for Discovery) at the 2019 SBUR

May 2016 - Session Co-Chair of Session I (Inflammation and metabosm alterations in urological diseases) at the 2016 SBUR

Research Areas

(1)  Development of novel technologies to image and target transcriptional and epigenetic regulation.

(2)  Regulation and function of AP-1 in prostate cancer cells. 

(3)  Mechanisms and targeting of therapy-induced neuroendocrine differentiation (NED) in prostate cancer. 

(4)  Role of PRMT5 in prostate cancer development, progression, and therapeutic response. 

(5)  Development of protein-protein interaction disruptors as novel cancer therapeutics. 

Professor Chang-Deng Hu, M.D., Ph.D.

Chang-Deng Hu Full CV